Found: 43
Select item for more details and to access through your institution.
MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage LIB-ILIB NSCLC.
- Published in:
- Clinical Lung Cancer, 2024, v. 25, n. 6, p. 587, doi. 10.1016/j.cllc.2024.06.007
- By:
- Publication type:
- Article
Pericardial Disease in Patients with Cancer: Clinical Insights on Diagnosis and Treatment.
- Published in:
- Cancers, 2024, v. 16, n. 20, p. 3466, doi. 10.3390/cancers16203466
- By:
- Publication type:
- Article
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 7, p. 1647, doi. 10.1007/s12094-024-03382-y
- By:
- Publication type:
- Article
Difficulties on the access to innovative targeted therapies for lung cancer in Spain.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 3, p. 597, doi. 10.1007/s12094-023-03303-5
- By:
- Publication type:
- Article
Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 11, p. 3139, doi. 10.1007/s12094-023-03286-3
- By:
- Publication type:
- Article
Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e69, doi. 10.1016/j.cllc.2021.10.009
- By:
- Publication type:
- Article
Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer (RELAY): Phase Ib Results.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation- Positive Metastatic Non—Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Elevated Levels of the Complement Activation Product C4d in Bronchial Fluids for the Diagnosis of Lung Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0119878
- By:
- Publication type:
- Article
Prognostic value of the preoperative lymphocyte-to-monocyte ratio for survival after lung cancer surgery.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correction: ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer: Alexandra Leary.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12501-5
- By:
- Publication type:
- Article
KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target.
- Published in:
- Molecular Cancer, 2018, v. 17, p. 1, doi. 10.1186/s12943-018-0789-x
- By:
- Publication type:
- Article
Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 341, doi. 10.1007/s00262-019-02310-2
- By:
- Publication type:
- Article
Urinary Cytokines Reflect Renal Inflammation in Acute Tubulointerstitial Nephritis: A Multiplex Bead-Based Assay Assessment.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 13, p. 2986, doi. 10.3390/jcm10132986
- By:
- Publication type:
- Article
Gene Expression Profiling as a Potential Tool for Precision Oncology in Non-Small Cell Lung Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4734, doi. 10.3390/cancers13194734
- By:
- Publication type:
- Article
Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4168, doi. 10.3390/cancers13164168
- By:
- Publication type:
- Article
Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implications.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 2, p. 453, doi. 10.1002/1878-0261.13550
- By:
- Publication type:
- Article
A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11153-1
- By:
- Publication type:
- Article
Encephalitis Induced by Immune Checkpoint Inhibitors: A Systematic Review.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 7, p. 864, doi. 10.1001/jamaneurol.2021.0249
- By:
- Publication type:
- Article
Transcriptional profiling of molecular pathways allows for the definition of robust lung squamous cell carcinoma molecular subtypes with specific vulnerabilities.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 9, p. 1, doi. 10.1002/ctm2.1413
- By:
- Publication type:
- Article
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 7, p. 1, doi. 10.1002/ctm2.491
- By:
- Publication type:
- Article
Clinical and economic impact of current ALK rearrangement testing in Spain compared with a hypothetical no-testing scenario.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients.
- Published in:
- Clinical Chemistry, 2017, v. 63, n. 3, p. 751, doi. 10.1373/clinchem.2016.265314
- By:
- Publication type:
- Article
Urinary soluble PD-1 as a biomarker of checkpoint inhibitor-induced acute tubulointerstitial nephritis.
- Published in:
- Clinical Kidney Journal, 2024, v. 17, n. 8, p. 1, doi. 10.1093/ckj/sfae200
- By:
- Publication type:
- Article
Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes.
- Published in:
- Nature Communications, 2014, v. 5, n. 12, p. 5893, doi. 10.1038/ncomms6893
- By:
- Publication type:
- Article
Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Expert Consensus on the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 8, p. 553, doi. 10.1007/s40261-024-01379-7
- By:
- Publication type:
- Article
The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 4, p. 1163, doi. 10.1002/ijc.32865
- By:
- Publication type:
- Article
TRAIL receptors promote constitutive and inducible IL-8 secretion in non-small cell lung carcinoma.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 12, p. 1, doi. 10.1038/s41419-022-05495-0
- By:
- Publication type:
- Article
3D collagen migration patterns reveal a SMAD3-dependent and TGF-β1-independent mechanism of recruitment for tumour-associated fibroblasts in lung adenocarcinoma.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 6, p. 967, doi. 10.1038/s41416-022-02093-x
- By:
- Publication type:
- Article
Thyroid dysfunction induced by nivolumab: searching for disease patterns and outcomes.
- Published in:
- Endocrine (1355008X), 2019, v. 64, n. 3, p. 605, doi. 10.1007/s12020-019-01871-7
- By:
- Publication type:
- Article
A Novel Serum 4-microRNA Signature for Lung Cancer Detection.
- Published in:
- Scientific Reports, 2015, p. 12464, doi. 10.1038/srep12464
- By:
- Publication type:
- Article
BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4 / BAP1 and the Proteasome Subunit rpn-9 / PSMD13.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 6, p. 929, doi. 10.3390/cells12060929
- By:
- Publication type:
- Article
Intrinsic cancer subtypes-next steps into personalized medicine.
- Published in:
- Cellular Oncology (2211-3428), 2015, v. 38, n. 1, p. 3, doi. 10.1007/s13402-014-0203-7
- By:
- Publication type:
- Article
Clinical and economic impact of 'ROS1-testing' strategy compared to a 'no-ROS1-testing' strategy in advanced NSCLC in Spain.
- Published in:
- 2022
- By:
- Publication type:
- journal article
RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51828-2
- By:
- Publication type:
- Article
Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: Experience beyond the clinical trials.
- Published in:
- Journal of the Peripheral Nervous System, 2020, v. 25, n. 2, p. 171, doi. 10.1111/jns.12371
- By:
- Publication type:
- Article
A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.578756
- By:
- Publication type:
- Article
RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and Manageability.
- Published in:
- Drug Safety, 2022, v. 45, n. 1, p. 45, doi. 10.1007/s40264-021-01127-2
- By:
- Publication type:
- Article
Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16952-9
- By:
- Publication type:
- Article